Harvest Fund Management’s Keysight KEYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9K Hold
27
﹤0.01% 428
2026
Q1
$8K Buy
+27
New +$6.76K ﹤0.01% 448
2025
Q1
Sell
-2,428
Closed -$390K 758
2024
Q4
$390K Buy
+2,428
New +$391K 0.02% 367
2023
Q3
Sell
-52
Closed -$9K 668
2023
Q2
$9K Sell
52
-321
-86% -$49.8K ﹤0.01% 565
2023
Q1
$60K Sell
373
-1,295
-78% -$220K 0.01% 446
2022
Q4
$285K Hold
1,668
0.07% 162
2022
Q3
$263K Buy
1,668
+914
+121% +$146K 0.08% 148
2022
Q2
$104K Hold
754
0.03% 287
2022
Q1
$119K Sell
754
-992
-57% -$165K 0.02% 310
2021
Q4
$361K Buy
1,746
+1,441
+472% +$270K 0.06% 142
2021
Q3
$50K Hold
305
0.01% 399
2021
Q2
$46K Hold
305
﹤0.01% 449
2021
Q1
$43K Hold
305
﹤0.01% 464
2020
Q4
$40K Buy
+305
New +$35.1K ﹤0.01% 395
2020
Q2
Sell
-572
Closed -$47K 486
2020
Q1
$47K Buy
572
+117
+26% +$11.1K 0.01% 306
2019
Q4
$46K Hold
455
﹤0.01% 290
2019
Q3
$44K Hold
455
0.01% 285
2019
Q2
$41K Buy
+455
New +$38.6K ﹤0.01% 315

Other funds holding KEYS

Harvest Fund Management's KEYS Position: Q2 2026 in Review

Harvest Fund Management held its Keysight (KEYS) position steady in Q2 2026 at 27 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #428.

Harvest Fund Management first reported a position in KEYS in Q2 2019 and has held it in 18 quarters since. The position peaked at $390K in Q4 2024. 1,253 funds tracked by Wall St. Rank hold KEYS as of Q2 2026.

  • Harvest Fund Management held 27 shares of Keysight worth $9K as of Q2 2026.
  • Harvest Fund Management left its Keysight share count unchanged in Q2 2026.
  • Keysight made up ﹤0.01% of Harvest Fund Management's portfolio in Q2 2026, its #428 holding.
  • Harvest Fund Management first reported a position in Keysight in Q2 2019 and has held it in 18 quarters since.
  • Harvest Fund Management's Keysight position peaked at $390K in Q4 2024.
  • 1,253 funds tracked by Wall St. Rank held Keysight as of Q2 2026.

Based on Harvest Fund Management's 13F filing for Q2 2026, filed 20 Aug 2026.